Filing status
- Accounts due
- 29 June 2027
- Last accounts
- 29 September 2025
- Conf. stmt due
- 29 September 2027
- Last conf. stmt
- 15 September 2026
Manx Pharma Ltd
- Incorporated
- 24 September 1996 (30 years)
- Industry
- Manufacture of basic pharmaceutical products (21100) Manufacture of pharmaceutical preparations (21200)Wholesale of pharmaceutical goods (46460)
- Owned by
- Accounts type
- Total exemption full
- Region
- West Midlands
- Address
- Unit 2 Bosworth AvenueTournament FieldsWarwickCV34 6UQ
Charges
- Total
- 7
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 7
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 26 July 2019
British
Born August 1991 (35)
Taylor, Laurence Dudley
Secretary · Appointed 9 February 2015
British
Director · Appointed 1 August 2001
British
Born June 1958 (68)
Officer history (9 former)
26 July 2019
26 July 2019
13 March 2015
13 March 2015
9 February 2015
Appointed Taylor, Laurence Dudley as Secretary
9 February 2015
9 September 2003
1 August 2001
1 August 2001
1 August 2001
1 August 2001
1 August 2001
19 October 2000
Resigned Litton, David Clive as Director
13 November 1997
Appointed Litton, David Clive as Director
26 June 1997
4 October 1996
4 October 1996
4 October 1996
4 October 1996
24 September 1996
24 September 1996
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 30 January 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 12539393
Former controllers (2)
30 January 2024
Ceased Rebel Holdco Limited — Owns 75–100% of shares
30 January 2024
Ceased Richard's Pharma Limited — Owns 75–100% of shares
Group structure 4 companies
Ownership group derived from the Companies House PSC register
Manx Healthcare Limited Owns 75–100% of shares
Manx Generics Limited Owns 25–50% of shares
Manx Pharma Ltd This company Owns 75–100% of shares
Financials
Balance sheet as at 29 September 2025 · total exemption full accounts
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fixed Assets | £0 | £125,000 | £125,000 | ||||
| Debtors | £845,503 | £105,227 | £101,804 | £92,487 | £335 | £335 | |
| Creditors (< 1 year) | £467,918 | £438,743 | £434,894 | £436,297 | £435,962 | £344,760 | £364,180 |
| Net Current Assets | £377,585 | (£333,516) | (£334,493) | (£343,475) | (£344,425) | (£363,845) | |
| Shareholder Funds | £377,585 | (£333,516) | (£334,493) | (£343,475) | (£219,425) | (£238,845) |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
King's Lynn
Lancaster
Nottingham
London
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →